Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Basit Öğe Kaydı
dc.contributor.authorKilickap, S.
dc.contributor.authorOzturk, A.
dc.contributor.authorKaradurmus, N.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorYumuk, P.
dc.contributor.authorCicin, I.
dc.contributor.authorPaydas, S.
dc.date.accessioned2024-04-24T17:50:04Z
dc.date.available2024-04-24T17:50:04Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS478en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue10en_US
dc.identifier.startpageS477en_US
dc.identifier.urihttps://hdl.handle.net/11468/23191
dc.identifier.volume13en_US
dc.identifier.wosWOS:000454014501235
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal of Thoracic Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNsclcen_US
dc.subjectAlk Inhibitoren_US
dc.subjectCrizotiniben_US
dc.titleCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkeyen_US
dc.titleCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu